Skip to content

Effect of virtual reality combined with repetitive transcranial magnetic stimulation on musculoskeletal pain and motor development in children with cerebral palsy: a protocol for a randomized controlled clinical trial

Effect of virtual reality combined with repetitive transcranial magnetic stimulation on musculoskeletal pain and motor development in children with cerebral palsy: a protocol for a randomized controlled clinical trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069853
Enrollment
Unknown
Registered
2023-03-28
Start date
2023-03-31
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral palsy

Interventions

VR+rTMS group:VR, rTMS, and routine rehabilitation therapy
rTMS group:rTMS and routine rehabilitation therapies
Control group:sham rTMS and routine rehabilitation therapies

Sponsors

Xinhua Hospital Affiliated to Shanghai Jiaotong University, School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 10 Years

Inclusion criteria

Inclusion criteria: Children with spastic hemiplegia, aged from 3 to 10 years, Gross Motor Function Classification System (GMFCS) level I or II, without a history of brain trauma or brain surgery and contraindications of rTMS, VR, and rehabilitation training in 6 months fit the inclusion criteria.

Exclusion criteria

Exclusion criteria: Children who received any drugs or surgery to improve CP symptoms in 6 months or could not cooperate with VR treatment due to severe cognitive, visual, and hearing impairment will be excluded from this study.

Design outcomes

Primary

MeasureTime frame
Pain;

Secondary

MeasureTime frame
Gross Motor Function;Fine Motor Function;Faces pain scale;Balance function;Activities of daily living;Quality of life;Safety;

Countries

China

Contacts

Public ContactXin Li

Xinhua Hospital Affiliated to Shanghai Jiaotong University, School of Medicine

lixin02@xinhuamed.com.cn86-15121007776

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026